Eric Lefkofsky and the Important work of Tempus

Eric Lefkofsky may not be a household name for the majority of America but he is certainly someone that tech minded entrepreneurs have been paying attention to. Eric Lefkofsky is a billionaire tech guru out of Chicago, IL who has been working in the data mining and aggregate world for a long time. As an entrepreneur he has pioneered some incredibly profitable and innovative companies. Now, Lefkofsky is setting his sights on working within the medical industry as he seeks to change the very way we approach cancer care and patient research.

Eric Lefkofsky has been focused on his work with start up company Tempus for the better part of the past two years. The company recently raised an additional $70 million in series C Funding and is now labeled at a $700 million valuation. All of the money in the world doesn’t compare to what Tempus is actually doing, however, and that is something that we will tackle with more specificity.

Tempus is using a special kind of technology in order to pull in clinical data and genomic data from patients around the country into a central aggregate. Tempus operates something like a digital blanket which is then summarily laid over the Electronic Health Records that hospitals have been familiarizing themselves with over the past several years. Lefkofsky and the team at Tempus understand just how haphazard data collection has been for cancer care patients and they know that proper data collecting can be the difference between life and death. After all, being able to find out why a certain medication works on one patient while not working on the other is well worth the knowledge!

Tempus is working hand in hand with a variety of different facilities as they seek to bully their way into the healthcare industry. Tempus has partnered up with the famous May Clinic as well as the Duke University School of Medicine and the Cleveland Clinic, as well. With progress Tempus will become a leading source of data on patient care and molecular information for patients around the country and eventually the world.